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The small bowel is essential to sustain alimentation and small bowel Crohn’s disease (CD) may severely limit its function. Small
bowel imaging is a crucial element in diagnosing small bowel CD, and treatment control with imaging is increasingly used to
optimize the patients outcome. Thereby, capsule endoscopy, Balloon-assisted enteroscopy, and Magnetic resonance imaging have
become key players to manage CD patients. In this review, role of small bowel imaging is detailed discussed for use in diagnosing
and managing Crohn’s disease patients.
1.Introduction
Crohn’s disease (CD) is a chronic inﬂammatory bowel disor-
der, and the patient might undergo recurring acute relapses.
The disease is lifelong lasting and frequently manifests in
t h eﬁ r s td e c a d e so fl i f e .T h es m a l lb o w e li si n v o l v e di nm o r e
than two-thirds of patients. In some patients, refractory in-
ﬂammation or chronic strictures of the small bowel are
responsible for a debilitating course of the disease that might
lead into malnutrition and a severely reduced quality of
life. Therefore, the small bowel warrants special attention in
diagnosing and treating CD.
Ideally, diagnostic tools that reveal small bowel CD
shouldbewithoutobjectiontorepeatthem,easyandpromp-
tly to apply, and well tolerable. Many of these requirements
are satisﬁed by modern diagnostics and imaging techniques.
Recently, the small bowel has come within reach of easy-to-
apply endoscopy, that is, capsule endoscopy (CE), balloon-
assisted enteroscopy (BAE), and spiral enteroscopy. High-
quality cross-sectional imaging complements endoscopy,
and percutaneous ultrasound (US) and magnetic-resonance
imaging (MRI) are at hand for an optimal steering instru-
ment of treatment regimens.
Recently, endoscopy is increasingly used to control the
eﬀectofmedicaltreatmentinclinicalpracticeofCDpatients.
When former studies were referring on symptom improve-
ment, only [1], more and more studies include “objective”
parameters such as endoscopic or radiologic ﬁndings to
supervise the patient [2–5]. Primarily, the concept of endo-
scopic surveillance was established in the detection of post-
o p e r a t i v er e c u r r e n c es o m e2 0y e a r sa g o[ 3]. With the evi-
denceofcompletemucosalhealinginmodernimmunomod-
ulation therapies, arguments for endoscopic treatment con-
trol are getting stronger [4, 5].
This review updates on new small bowel imaging meth-
ods and their impact on managing small bowel CD.
2. Capsule Endoscopy
Small bowel video CE oﬀers a noninvasive and easy-to-
apply investigation of the small bowel. The video capsule
is ingested and passes the intestinal tract by use of natural
peristalsis. Thereby, images are continuously acquired until
battery exhaustion and are registered at the storage device
that the patient wears as his belt. Imaging data are afterwards
reviewed by a specialist on a computer workstation. Most
systems oﬀer online visualization of the endoscopic proce-
dure, but this feature is mainly used to conﬁrm passage
progress and not to detect a lesion. At present, there are
several commercially available CE systems on the market
that diﬀer somehow in terms of technical details or soft-
ware features: PillCam SB2, Given Imaging, Yoqneam, Israel
(http://www.givenimaging.com/); EndoCapsule, Olympus
Europe GmbH, Hamburg, Deutschland, (http://www.olym-
puseuropa.com/endoscopy/); CapsoVision, Saratoga, Ca,
USA, (http://www.capsovision.com/); OMOM, Chongqing2 Gastroenterology Research and Practice
Table 1: Four capsule endoscopes are available at present.
Capsule Company Size (mm) Frame rate (Images/s) Field of view Acquisition time (hours)
PillCam SB 2 Given Imaging, Israel 26 × 11 2 156◦ 8 (SB 2); ca. 12–16 (SB 2L)
EndoCapsule Olympus, Japan 26 × 11 2 145◦ > 8
MiroCam IntroMedic, Korea 25 × 11 3 — > 11
OMOM Chongqing Jinshan Science, China 28 × 13 2 or 1 140◦ 8
CapsoVision CapsoVision Inc. 31 x 11.3 0–5 360 15
Figure 1: Crohn’s disease of the small bowel in capsule endoscopy: multiple small ulcerations all over the ileum and jejunum, scarring
alterations of the small bowel.
Jinshan Science, Beijing, China, (http://www.cqjs.net/);
Miro-Cam, IntroMedic, Seoul, Korea (http://www.intro-
medic.com/). In the USA, only the PillCam SB2 and the En-
doCapsule are currently approved by the US Food and Drug
Administration, and in Europe, all the four systems can be
purchased in most countries. Widely spread is the PillCam
SB 2 capsule that has been used for almost all studies on CE
in CD. The PillCam SB2 uses a CMOS chip with a resolution
of 0.1mm at a magniﬁcation of 1:8. Battery life is 8h (SB 2)
to about 12–16 hours (SB 2L); Table 1; Figure 1.
CE is usually not used in patients with intestinal stric-
tures or potential stenosis for fear of retention. Dysphagia
is a relative contraindication for CE, but the capsule might
be placed in the duodenum by means of esophagogastro-
duodenoscopy (EGD) in case of swallowing disorders or gas-
troparesis. Pregnancy and any implanted medical device are
still considered contraindications, but there is an increasing
experience with the use of the PillCam capsule in patients
with cardiac pacemakers or deﬁbrillators. Thereby, interfer-
ence for disadvantage of the patient has not been reported
[22]. The main limitation of the capsule is the lack to take
biopsies or to perform interventions, the diﬃculty to exactly
localize identiﬁed lesions, and to control its movement. By
administering patency capsule before doing video CE, cap-
sule retention can be reliably prevented [23, 24]. The patency
system (i.e., given AGILE patency capsule) is designed to
determinewhichpatientswithknownorsuspectedintestinal
strictures can safely ingest a video capsule endoscope. The
capsule is of similar size to the endoscopy capsule, but is
made of lactose and barium and dissolves within 32 to 72
hours of entering the GI tract. Excretion of the intact capsule
withoutsymptomspredictstheuncomplicatedpassageofthe
wireless capsule endoscope.
3.Balloon-AssistedEnteroscopy(BAE)
Balloon-assisted enteroscopy (BAE) was ﬁrst introduced in
2003 [25]. BAE allows deeper intubation of the SB compared
with push enteroscopy (PE) and ileocolonoscopy (IC). BAE
involves push-and-pull maneuvers for deep intubation of
the small bowel [26], and single- and double-balloon enter-
oscopes (SBE and DBE) are presently available [27]; Table 2.
Rate of complete small bowel investigations seems to be
more regularly achievable using double-balloon instead of
single-balloon technique as reported in randomized studies
(Table 3), but therapeutic impact was similar to SBE and
DBE. Preference for SBE or DBE depends on the experience
and predilection of the endoscopic centre.
Carbon dioxide insuﬄation instead of using ambient air
increases intubation depth and signiﬁcantly reduces incon-
venience of the patient and may therefore be preferred for
allballoon-enteroscopyinterventions [28,29].Complication
rates are low in diagnostic BAE (<5%) and include pancre-
atitis (<1%), bleeding, and perforation, and rate of com-
plications increases in therapeutic interventions [30].
4.SpiralEnteroscopy(SE)andOthers
Enteroscopy with the Endo-Ease system (Spirus Medical,
Stoughton, MA) uses a spiral-shaped overtube of 118cmGastroenterology Research and Practice 3
Table 2: Balloon-assisted enteroscopy. Technical data of the scopes that are presently available.
Device Company Working channel
(mm)
Length
(mm)
Working length
(mm)
Diameter of
distal part (mm)
Length of
overtube (mm)
Diameter of overtube
(mm)
DBE EN-450P5 Fuji 2.2 2300 2000 8.5 1450 12.2 (outer diameter)
8.7–10 (inner diameter)
DBE EN-450T5 Fuji 2.8 2300 2000 9.4 1450 13,2 (outer diameter)
9.8–10.8 (inner diameter)
SBE SIF-Q180 Olympus 2.8 2300 2000 9.2 1320 13mm (ST-SB1)
Table 3: Comparison of single-balloon (SBE) or double-balloon technique (DBE) in prospective, randomized studies.
Author
Year n
Complete enteroscopy Diagnostic yield Therapeutic yield
SBE DBE SBE DBE SBE DBE
May et al. [6] 2010 100 22% 66% 42% 52% 42% 52%
Domagk et al. [7] 2011 150 11% 18% 37% 43% 5% 9%
Takano et al. [8] 2011 38 0% 57% 61% 50% 28% 35%
with a spiral of 0.55cm high and 22cm long and can be used
with enteroscopes of less than 9.4mm in diameter. The
enteroscope is advanced or withdrawn with rotatory clock-
wise and counterclockwise movements of the spiral. Endos-
copy of the small bowel by SE is reported to be safe [31]
and seems to reduce the examination time, but the insertion
depth is minor in comparison to DBE [32–34]. In Crohn’s
disease patients, SE has rarely been performed up to now.
5.RadiologyinImagingSmallBowel
Crohn’s Disease
Visualizationofthesmallbowelwithcross-sectionalimaging
methods requires distension of the intestines to identify the
conﬁguration of the bowel loops and to improve charac-
terization of the bowel wall with luminal contrast. This is
achieved by inserting a nasojejunal tube into the proximal
small bowel (enteroclysis) or with oral intake of the luminal
contrast medium (enterography). Conventional ﬂuoroscopy
(small bowel follow-through and small bowel enteroclysis)
has thereby almost completely been replaced by cross-
sectional imaging methods. Computed tomography (CT)
and MRI are available as CT-enterography/CT-enteroclysis
(CT-E) or MR-enterography/MR-enteroclysis (MR-E) with
oral intake providing similar quality images but with an
improved patient comfort over tube-assisted infusion of
enteral contrast [15, 35, 36]. MR and CT equally provide ex-
cellent information on inﬂammatory alterations of the small
bowel and also of extraluminal complications (abscess,
ﬁstula),thusaddingusefulinformationonendoscopicinves-
tigations; Table 4.
Largelifetimedosesofradiationareaconcernparticular-
ly in young patients. CD patients are at risk for an increased
exposure, and the often young age at the initial diagnosis has
a signiﬁcant inﬂuence on lifetime risk [37]. Radiation doses
of more than 100mSv may be observed in some patients.
Lack of radiation exposure and excellent soft tissue contrast
argue for use of MRI in CD patients and against ﬂuoroscopy
or CT [38–42].
6. Percutaneous Ultrasonography for
Detectionof SmallBowelCrohn’sDisease
Percutaneous ultrasonography (US) is useful to detect small
bowel CD and to reveal extraintestinal complications, for
example, abscess or ﬁstula. Sensitivity of the technique is
improved with the use of enteral contrast medium, such as
polyethylene glycol [41]. Overall accuracy might be minor to
endoscopy, but an experienced investigator can beneﬁcially
use US as an initial diagnostic tool for managing CD patients
[42].
7.DiagnosingSmallBowelCrohn’s
Disease: Endoscopy inComparison
toRadiologicImaging
Small bowel endoscopy and MR-E/CT-E are accepted as a
diagnostic standard to evaluate small bowel CD, but diag-
nostic sequence and clear deﬁnition of applying endoscopy
versuscross-sectionalimagingisunderdebate.Meta-analysis
of studies comparing diagnostic yield and value of CT-E,
MR-E, CE, and other methods were published in 2006 [43]
and 2010 [44]. Thereby, higher sensitivity of endoscopic
methods, for example, CE, to detect small bowel lesions was
clearly demonstrated; Table 5.
Next to high sensitivity, endoscopy has an excellent nega-
tive predictive value to exclude manifestation of small bowel
CD. But endoscopic and radiologic ﬁndings are far from
being pathognomonic, and small bowel ulceration may sim-
ilarly be compatible with chronic inﬂammatory, neoplastic,
and infectious origin or might be secondary to NSAID in-
take. In a cohort of patients who were suspected to be af-
ﬂicted with small bowel CD, 37% of 102 patients were
initially diagnosed with small bowel ulcerations in CE, but
in only 13% the diagnosis of CD was maintained at one year
of followup [45]. This reﬂects the “old” wisdom, that diag-
nosing CD is based on many clinical data including follow-
up of the patient. Even if some features of small bowel
lesions might rather suggest CD (irregular and longitudinal4 Gastroenterology Research and Practice
Table 4: Comparing pros and cons of CT versus MRI in use in Crohn’s disease patients; CT-enterography/CT-enteroclysis (CT-E) or MR-
enterography/MR-enteroclysis (MR-E).
CT-E MR-E
Pro Con Pro Con
High resolution in contrast-rich
objects (e.g., bone versus parenchyma)
Excellent contrast in soft
tissues; contrast uptake into
tissues is well visualized
Fast acquisition time, minor motion
artifacts
Increased acquisition time,
prone to motion artifacts
Widely spread technique Higher cost and less
available
Abdomen and pelvis are a one-step
investigation
Abdomen/pelvis are usually
diﬀerent examination
protocols
Radiation exposure No radiation exposure
Speciﬁc side eﬀects of contrast
medium
Speciﬁc side eﬀects of
contrast medium
Restriction in pace-maker
p a t i e n t sa n ds of o r t h
Table 5: Comparison of diagnostic yield or sensitivity in cross-sectional imaging and endoscopy in diagnosing small bowel Crohn’s disease;
CTE: computed tomography enterography; MRI: magnetic resonance imaging.
Author Year of publication N Capsule endoscopy Comparator (cross-sectional imaging) Statistical
signiﬁcance
Eliakim et al. [9] 2004 35 77% CTE 20% P<0.05
Voderholzer et al. [10] 2005 41 25/41 (61%) CTE 12/41 (29%) P = 0.004
Hara et al. [11] 2006 17 12/17 (71%) CT 9/17 (53%) n.s.
Solem et al. [12] 2008 28 83% CTE 83% n.s.
Albert et al. [13] 2005 52 25/27 (93%) MRI 21/27 (78%) n.s.
Golder et al. [14] 2006 18 12/18 (66%) MRI 1/18 (5%) P = 0.016
Jensen et al. [15] 2011 93 100% MRI and
CTE
81% (MRI) 76%
(CTE)
P<0.05 (for
proximal
small bowel)
ulcerations, multiple locations, and cobble stone aspect of
thesmallbowel)thanNSAIDuse(circularulcerations,webs)
or neoplasia (circumscribed lesion), these identiﬁers must be
interpreted cautiously before labeling a patient to be aﬀected
by CD.
8.DiagnosingSmallBowelCrohn’s
Disease:SuspectedCrohn’s Disease
In suspected CD, ileocolonoscopy is still the reference
standard in the diagnostic algorithm. Consensus conferences
therefore advised to keep to a speciﬁc diagnostic sequence
in suspected CD: ﬁrst, ileocolonoscopy is used to diagnose
ileitis terminalis or colitis, this is followed by cross-sectional
imaging to identify proximal CD or extraenteric lesions, and
CE is regarded a ﬁnal identiﬁer for detection of small bowel
lesions that are reason for unexplained symptoms [46, 47].
These recommendations have not yet considered recent
study results demonstrating equal validity to detect terminal
ileitis for CT-E, MR-E, and CE. Moreover, signiﬁcantly
better detection of proximal small bowel involvement may
be expected for CE [15]. Moreover, high negative predictive
value of CE of 90 to 100% suggests using CE to exclude
CD in suspected disease cases. Therefore, CE could be con-
sidered an early step in suspected CD and nonconclusive
colonoscopy in the future. To exclude neoplastic and infec-
tious disease, ﬂexible enteroscopy should regularly be per-
formed to take biopsies in lesions found by CE. Cross-sec-
tional imaging (e.g., US, MRI) is indicated to screen for
extraintestinal disease. Studies are not yet available that
might support the use of CE to investigate the small bowel
plus the colon in a “one-step shopping” approach using the
colon capsule endoscope.
9.DiagnosingSmallBowelCrohn’s
Disease:Established Crohn’sDisease
In established CD, value of cross-sectional imaging (e.g.,
MRI) surpasses endoscopic information in many clinical
scenarios such as the septic patient, and acute onset of severe
complaints and pain. Severe inﬂammations of bowel seg-
ments, suppurative disease, and conglomerate tumor orGastroenterology Research and Practice 5
Table 6: Balloon dilation for symptomatic small bowel strictures with the use of balloon-assisted enteroscopy; Small bowel strictures in
anastomotic and nonanastomotic Crohn’s disease.
Author
Year n
Balloon dilation
Complication
Technical success Clinical response Failed
Yamamoto et al. [16] 2004 6 6 6 6 None
Pohl et al. [17] 2007 19 8 6 13 None
Fukumoto et al. [18] 2007 23 22 17
2( S u r g e r y )4
(repeated
dilation)
None
Despott et al. [19] 2009 11 9 8 2 Perforation (n = 1)
Hirai et al. [20] 2010 25 18 18 7 n = 2
Kondo et al. [21] 2010 12 8 7 1 None
ﬁstulaearetherebydetected.Performanceofileocolonoscopy
and/or small bowel endoscopy is necessary to discriminate
inﬂammatory from chronic-scarring bowel changes or stric-
tures. Indication for BAE has to be balanced against CE
preferring ﬂexible endoscopy in suspicion of high grade
strictures or in case the “patency capsule” failed to pass the
intestines.
10. Colitis withan UnclassiﬁedTypeof
Inﬂammatory BowelDisease(IBDU)
In colitis with an unclassiﬁed type of inﬂammatory bowel
disease (IBDU), small bowel inﬂammation could be the clue
to conﬁrm the diagnosis of CD in some patients. The diag-
nosis of IBDU had been revised and changed to CD in 15%
of 120 patients in one study in which small bowel ulcerations
were detected [48, 49]. Discrete ﬁndings should not mislead
torevisethediagnosis,despite[50],andnegativesmallbowel
CE might not completely exclude CD—for example, of the
colon [49].
In the postoperative situation, endoscopic surveillance
of the patient has been recommended [47], and endoscopy
seems essential to discriminate inﬂammatory from nonin-
ﬂammatory bowel alterations. CE might replace ileocolon-
oscopy to detect recurrence: accuracy of CE to detect inﬂam-
mation near to the anastomosis is similar to conventional
colonoscopy, but proximal disease is exclusively visualized by
CE [41, 51, 52].
11. Endoscopic Treatment inCrohn’s Disease
FlexibleendoscopyoﬀerstreatmentoptionsforCDstrictures
in selected cases. Balloon dilation has been expanded from
colonic and anastomotic stricture to the whole of the small
bowelbyuseofBAE,andsymptomaticsmallbowelstrictures
maybetreatedatanastomoticandnonanastomoticsiteswith
a justiﬁable risk proﬁle (Table 6). Balloon dilation might well
be repeated in recurring strictures.
12. Imaging for Treatment Control
Imaging is used to control treatment and to assess prognosis
in Crohn’s disease patients, but this is far from routine
practice. New concepts of modern treatment regimes that
aim to attain complete mucosal healing support to verify
treatment success using diagnostic procedures and a new
verve for imaging to help managing CD patients may
recently be noticed [53]. Nevertheless, studies keep relying
onclinicaloutcomewithoutsupportingsubjectiveendpoints
such as imaging data [1]. But introduction of objective study
outcomes, for example, by assessing endoscopic activity of
CD before and after treatment is increasingly reported, for
example, in the postoperative situation [2–5]. Interestingly,
we know for over 20 years that endoscopic activity predicts
course of the disease in high-risk, postoperative patients [3],
and endoscopic treatment control in this patient group is
well established [54]. Control of mucosal healing has been
used to assess treatment eﬃcacy in ulcerative colitis, but in
CD, this concept has only emerged after biological therapies
have been evaluated in clinical trials. Even if mucosal
healing has been shown to reduce hospitalizations and
surgery, strong correlation of mucosal healing and symptom
improvement has not been proven yet [5]. Today, in clinical
practice, endoscopy is used to assess mucosal healing in
patients with persistent symptoms despite therapy and when
treatment discontinuation is considered. Further studies
have to provide the value of managing all CD patients with
endoscopic or radiologic imaging.
13. Conclusion
Small bowel imaging is a crucial element in diagnosing
small bowel CD, and CE, BAE, and MRI have become key
players to manage CD patients. Treatment control is strongly
advised in the patient who had formerly undergone bowel
resection, but is increasingly used to testify treatment success
in many patients. Endoscopy is indispensable for diagnosis
at ﬁrst presentation, and cross-sectional imaging is the ﬁrst-
line diagnostic means in established disease and presentation
with severe disease. Thus, complementary use of cross-sec-
tional imaging and endoscopy is essential for the best beneﬁt
of the patient.
Abbreviation
APC: Argon plasma coagulation
BAE: Balloon-assisted enteroscopy6 Gastroenterology Research and Practice
CE: Capsule endoscopy
CT: Computed tomography
CT-E: CT-enteroclysis/enterography
DBE: Double-balloon enteroscopy
EGD: Esophagogastroduodenoscopy
ERC: Endoscopic retrograde cholangiography
IBDU: Unclassiﬁed type of inﬂammatory bowel
disease
MR-E: MR-enteroclysis/enterography
MRI: Magnetic resonance imaging
NSAID: Nonsteroidal anti-inﬂammatory drugs
SBE: Single-balloon enteroscopy
TTS: Through the scope
US: Percutaneous ultrasonography.
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